Element Capital Management LLC Gilead Sciences, Inc. Transaction History

Element Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$57.72 - $65.01 $610,735 - $687,870	10,581 Added 50.0%	31,743 $1.96 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $1.23 Million - $1.54 Million	21,162 New	21,162 $1.26 Million
Q4 2019 Feb 12, 2020	SELL	$61.62 - $67.78 $2.87 Million - $3.16 Million	-46,646 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $2.92 Million - $3.22 Million	46,646 New	46,646 $2.96 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $238,632 - $267,598	-3,857 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$62.53 - $70.05 $3.3 Million - $3.7 Million	-52,796 Reduced 93.19%	3,857 $251,000
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $1.27 Million - $1.66 Million	-20,978 Reduced 27.02%	56,653 $3.54 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $1.39 Million - $1.54 Million	19,506 Added 33.56%	77,631 $5.99 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $2.53 Million - $2.95 Million	38,993 Added 203.81%	58,125 $4.12 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $1.39 Million - $1.7 Million	19,132 New	19,132 $1.44 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Element Capital Management LLC with notifications on news.